Drug name - Gimoti
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11020361 | EVOKE PHARMA INC | Nasal formulations of metoclopramide |
Dec, 2029
(7 years from now) | |
| US8334281 | EVOKE PHARMA INC | Nasal formulations of metoclopramide |
May, 2030
(7 years from now) | |
Drugs and Companies using METOCLOPRAMIDE HYDROCHLORIDE ingredient
Treatment: Nasal administration of metoclopramide for treatment of diabetic gastroparesis
Dosage: SPRAY, METERED;NASAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 15MG BASE/SPRAY | SPRAY, METERED;NASAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.